Cargando…
Extended field or pelvic intensity-modulated radiotherapy with concurrent cisplatin chemotherapy for the treatment of post-surgery multiple pelvic lymph node metastases in cervical cancer patients: a randomized, multi-center phase II clinical trial
BACKGROUND: To prospectively compare the outcomes and side effects between groups of postoperative cervical cancer patients with multiple pelvic lymph node metastases who were treated with extended field or pelvic intensity-modulated radiotherapy (IMRT) with concurrent cisplatin chemotherapy. METHOD...
Autores principales: | Luo, Weiming, Li, Yunhai, Ke, Guihao, Wu, Xiaohua, Huang, Xiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8798010/ https://www.ncbi.nlm.nih.gov/pubmed/35116266 http://dx.doi.org/10.21037/tcr-20-2573 |
Ejemplares similares
-
Prophylactic extended-field irradiation with concurrent chemotherapy for pelvic lymph node-positive cervical cancer
por: Oh, Jinju, et al.
Publicado: (2017) -
Value of imaging study in predicting pelvic lymph node metastases of uterine cervical cancer
por: Jung, Wonguen, et al.
Publicado: (2017) -
The distribution pattern of pelvic lymph nodal metastases in cervical cancer
por: Xie, Shangdan, et al.
Publicado: (2023) -
Human Papillomavirus Status in Primary Lesions and Pelvic Lymph Nodes and Its Prognostic Value in Cervical Cancer Patients with Lymph Node Metastases
por: Chen, Peng, et al.
Publicado: (2019) -
Radiographic Number of Positive Pelvic Lymph Nodes as a Prognostic Factor in Cervical Cancer Treated With Definitive Concurrent Chemoradiotherapy or Intensity-Modulated Radiotherapy
por: Wang, Shih-Chang, et al.
Publicado: (2018)